{
  "docId": "019de075-8d44-7401-b489-ee436db9a207",
  "docSlug": "66ec60e76d61a423395d466c32dc56fb",
  "documentTitle": "Exscientia | Investor Presentation Deck | 75 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 40,
  "pageCount": 75,
  "prevPage": 39,
  "nextPage": 41,
  "slideType": "why_now",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "Includes a biological pathway diagram and a honeycomb-style indication map.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-8d44-7401-b489-ee436db9a207/40",
  "deckHref": "/decks/019de075-8d44-7401-b489-ee436db9a207",
  "deckJsonHref": "/decks/019de075-8d44-7401-b489-ee436db9a207.json",
  "deckAnchorHref": "/decks/019de075-8d44-7401-b489-ee436db9a207#slide-40",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.43,
        "y": 0.83
      },
      "kind": "callout",
      "text": "Potential for first line therapy or for CDK4/6 refractory patients",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0db7a897-6d10-4fad-bb53-b0a3aaf870d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.38,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Cell cycle and transcription pathway diagram",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "96ce9fa5-b9cc-4924-9f3a-28491c2a14d2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.3,
        "x": 0.1,
        "y": 0.65
      },
      "kind": "image",
      "text": "Honeycomb diagram of cancer indications",
      "attrs": null,
      "subkind": "infographic",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "108d0ddb-2994-443b-828f-d61585dbd431",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.5,
        "x": 0.43,
        "y": 0.26
      },
      "kind": "list",
      "text": "Importance of cell cycle inhibition: CDK4/6 inhibitors have demonstrated potential; Ibrance generated $5.4b in 2021; 65-75% of patients show response but acquire resistance.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "686a36b0-1060-4d60-9ed9-88c2c690351b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.5,
        "x": 0.43,
        "y": 0.53
      },
      "kind": "list",
      "text": "Transcription and cell cycle dysregulation are both hallmarks of cancer: Inhibiting both may be more effective; Aberrant CDK7 overexpression is common; Majority of cancers are 'transcriptionally addicted'.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "79d6762f-e00e-4c71-8d54-ac961e3a5b93",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.07,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "ER+: Oestrogen receptor positive. About 80% of all breast cancers are ER+. Source: Xu et al. 2020 Nature; Sava et al. 2020 Cancer and Metastasis Reviews",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "55a84bf7-4a52-4150-8f36-5cebd4823366",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.5,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "title",
      "text": "Dual targeting of cell cycle and transcription mechanisms",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "21d51cac-39e9-4ade-ac56-3aff46d331d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.07,
        "y": 0.06
      },
      "kind": "title",
      "text": "CDK7: Inhibition provides broad oncology opportunity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c3f36c3-7ff0-47a7-848a-e6246ccd8e9e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "2fabb0eb-8c56-4378-a69c-0693e7372a5f",
      "evidence": "list/bullet: Transcription and cell cycle dysregulation are both hallmarks of cancer: Inhibiting both may be more effective; Aberrant CDK7 overexpression is common; Majority of cancers are 'transcriptionally addicted'.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "causal-chain",
      "slug": null,
      "matchId": "b54cc279-2d96-4259-a60a-3bcedbf4d5cc",
      "evidence": "Diagram showing the link between CDK7, transcription, and cell cycle dysregulation.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}